Data Study Solutions

Precision Health Informatics data solutions combine insights from the patient journey with real-world experience, going beyond clinical trials to look back on outcomes based on best clinical judgement.

With access to more than 1.6 million patient records and more than 400,000 molecular profiles, Precision Health Informatics data solutions are delivered through a proprietary technology platform that is easily searchable and updated in real time.

The data provided also includes social determinants of health that are part of the new Enhancing Oncology Model (EOM). Based on the extensive patient database and diverse demographics of the patient population, Precision Health Informatics datasets are representative of the U.S. population.

Our Offerings

Precision Health Informatics is pleased to provide datasets and collaboration appropriate for several healthcare study models. Precision Health Informatics can facilitate access to a large and diverse patient population across a significant geographic footprint. These broad datasets can be used for different types of data projects, such as:

  • Non-interventional Studies
  • Drug Utilization Review
  • Real-world Data Studies
  • Clinical Trials: Patient Identification & Enrichment
  • Quality Measurements & Improvements

Drug Utilization Packages

Bronze

Silver

Gold

Platinum
Precision Medicine Bronze Package

Rx Treatment Utilization (Oral/IV), Rx fill status/number and Refill prescribed/remaining, Pharmacy Location Details (internal/External), Ordering Physician and Practice Location details

Payer and Claims Reporting

Precision Medicine Silver Package

Bronze Package Contents +

Regimen Line of Therapy (LOT), Duration of Therapy (DOT), Cycle Duration and Cycle Number

Diagnosis details: ICD codes, Stage

Precision Medicine Gold Package

Silver Package Contents +

Molecular Data Access: Biomarker testing details, protein/DNA Alterations, variant type/descriptions, methodology, clinical significance

Precision Medicine Platinum Package

Gold Package Contents +

Rx at-home adherence reporting, patient assessment details (pain survey, depression survey, distress survey)

Quality Measurements & Improvements

Solid tumor testing initiative

  • Somatic tissue testing by NGS
  • Liquid biopsy testing – rapid concordant
  • Trapelo tool for ordering tests
  • Collaboration between hospitals and pharmacy providers
  • Managing financial toxicity via Pharma/Lab partnerships
  • ~100% testing rates of eligible patients (double)
  • Access to clinical trials

Communication of actionable mutations

  • Positive biomarker results for K-ras G12 C and BRAF mutations communicated to provider via secure email
  • Germline testing results
  • Hematologic malignancies

Circulating DNA testing

  • Minimum residual disease can be detected and acted upon